As BRAF V600E testing is paramount in routine clinical testing in cutaneous melanoma, we aimed to compare ddPCR sensitivity with a CE-IVD validated RT-PCR assay when screening for these mutations in paraffin-embedded tissue samples. The gene discussed is BRAF; the disease is cutaneous melanoma.